- Immune Pharmaceuticals Inc. stock price today and history
Immune Pharmaceuticals Inc. (IMNP ) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
Immune Pharmaceuticals Inc. stock price
Immune Pharmaceuticals Inc. latest news:
Immune Pharmaceuticals shares surge 75% on positive mid-stage clinical trial results
Immune Pharmaceuticals Inc. shares surged 75% in premarket trade Wednesday after the company said early results from a phase 2 clinical trial for moderate-to-severe bullous pemphigoid were positive. Company shares closed at $1.20 on Tuesday. The results, which came from the first six patients enrolled in the clinical trial for Immune Pharmaceuticals' bertilimumab, found a decline in patients' total activity score for the condition of 85%. Patients' improvement was "rapid," the company said, with the activity score declining on average by 72% by day 42. Bullous pemphigoid is a rare skin condition that consists of large blisters that can be life-threatening, especially for already-sick older individuals, who the condition commonly afflicts, according to the Mayo Clinic. The company said it will continue to enroll patients in the phase 2 trial, with target enrollment of 12 to 15 patients, and has plans for a larger clinical trial. Immune Pharmaceuticals shares have declined 57.5% over the last three months, compared with a 3.2% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Impax Laboratories, Inc.IPXL
Imprimis Pharmaceuticals, Inc.IMMY
INC Research Holdings, Inc.INCR
Independent Bank Corp.INDB
Independent Bank CorporationIBCP
Independent Bank Group, IncIBTX